Raptor Pharmaceutical Corp (NASDAQ:RPTP)

During the Trading Day
13.83 -1.96 / -12.41%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.90 +0.07 / +0.51%
 
Volume: 23.8K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.3B

Company Description

Raptor Pharmaceutical Corp. is a biopharmaceutical company, which focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. It has active development programs in cystinosis, a rare genetic disease, as well as other genetic and metabolic disorders. Raptor Pharmaceutical Corp was founded by Christopher M. Starr & Todd C. Zankel on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
7 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional24.63%
Individual stakeholders22.14%
Mutual fund holders20.73%

Top Executives

Julie Anne SmithPresident, Chief Executive Officer & Director
Michael P. SmithCFO, Secretary, Treasurer & CAO
Todd C. ZankelChief Scientific Officer
Krishna R. PoluChief Medical Officer
Paul K. RossChief Compliance Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account